Pixelgen
Bringing a new spatial understanding to biology by developing tools to facilitate the mapping of cell surface proteins and their spatial inter-relationships.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €2.5m | Grant | |
| Total Funding | 000k | ||
| SEK | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 214 % | (62 %) | (35 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (64 %) | (85 %) | (606 %) | (1084 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Pixelgen is a leading innovator in the field of digital image processing and computer vision. The company specializes in developing advanced software and algorithms that enhance image quality, optimize data visualization, and enable precise image analysis for various applications.
Pixelgen’s solutions are designed to address complex challenges across multiple industries, including healthcare, automotive, and security. Their technology is utilized to improve imaging systems, facilitate accurate diagnostics, and drive innovations in automated visual inspections.
With a commitment to pushing the boundaries of visual technology, Pixelgen leverages cutting-edge research and development to deliver high-performance tools that empower businesses and researchers to unlock new insights and efficiencies. Their products are known for their reliability, scalability, and integration capabilities, making them a trusted partner in advancing the future of digital imaging.